Skip to content

Public FDA record

Z-1704-2024: IPS e.max ZirCAD CER/in. Prime A1 C17/5 - A zirconium oxide block for the fabrication of fixed, full-cont

Recall record Z-1704-2024 for IVOCLAR VIVADENT AG. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1704-2024
Company in FDA record
IVOCLAR VIVADENT AG
FDA classification date
Apr 30, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Defective blocks may show cracks after sintering If cracks are unnoticed, restorations may fracture in the patient's mouth and require restoration

Source facts

Action
Ivokar issued Urgent Use and Safety Notice (03-2024-003-R) Letter to Distributors/End users via Fed'X or Email on 4/05/24. Letter states reason for recall, heath risk and action to take: 1. Identification of the IPS e.max ZirCAD Prime CEREC/inLab, C17 Block batches affected by the recall. 2. Separate the blocks so that they can no longer be used for the fabrication of dental restorations. 3. Contact the Customer Service of the distributor from whom you purchased the affected IPS e.max ZirCAD Prime CEREC/inLab, C17 Blocks to announce the return of the devices. Please note on the delivery bill Recall Ivoclar Vivadent AG (03-2024-003-R) . Your distributor will collect the devices affected by the recall and return them to Ivoclar. 4. In addition, please complete the Customer Reply Form in the attachment and send the completed form to vigilance.li@ivoclar.com. 1. Queries regarding the Risk Minimising Safety Measures described in this Field Safety Notice should be addressed to: Responsible Department at Manufacturer of the Devices: Global Vigilance Email vigilance.li@ivoclar.com Postal Address Ivoclar Vivadent AG Customer Care Global Vigilance Bendererstrasse 2 FL-9494 Schaan Liechtenstein All queries by email will be answered within one working day (24 hours). If you have given the products to a third party, please forward a copy of this information or inform Global Vigilance via vigilance.li@ivoclar.com. 2. Queries regarding replacement for the IPS e.max ZirCAD Prime CEREC/inLab, C17 Block affected by this field safety notice please contact the customer service of your distributor of the Ivoclar Vivadent AG device. We will arrange all refunds with your responsible distributor. Your distributor will check the availability of the replacement material with Ivoclar Partner Support and let you know when the replacement material will be shipped to you.
Initiated
2024-04-05
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution.
Recall number
Z-1704-2024
Recall status
Open, Classified
CDRH record ID
207166
FDA classified
2024-04-30
Recall event number
94401

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗